A Safe-by-Design Approach for the Synthesis of a Novel Cross-Linked Hyaluronic Acid with Improved Biological and Physical Properties

Author:

Sciabica Sabrina1,Barbari Riccardo1ORCID,Fontana Riccardo2ORCID,Tafuro Giovanni3,Semenzato Alessandra4ORCID,Traini Daniela56ORCID,Silva Dina M.6,Reis Larissa Gomes Dos6,Canilli Luisa7,Terno Massimo7,Marconi Peggy2ORCID,Baldisserotto Anna1ORCID,Vertuani Silvia1,Manfredini Stefano1ORCID

Affiliation:

1. Department of Life Sciences and Biotechnology, University of Ferrara, via L. Borsari 46, 44121 Ferrara, Italy

2. Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, via Fossato di Mortara 64/B, 44121 Ferrara, Italy

3. Unired Srl, via Niccolò Tommaseo 69, 35131 Padova, Italy

4. Department of Pharmaceutical and Pharmacological Sciences, University of Padova, via Marzolo 5, 35131 Padova, Italy

5. Macquarie Medical School, Faculty of Medicine, Health & Human Sciences, Macquarie University, Campus Macquarie Park, Sydney 2109, Australia

6. Woolcock Institute of Medical Research, 431 Glebe Point Road, Glebe, Sydney 2037, Australia

7. Istituto Ganassini S.p.a., Via Carlo Boncompagni, 63, 20139 Milano, Italy

Abstract

Hyaluronic acid (HA) is a polymer with unique biological properties that has gained in interest over the years, with applications in pharmaceutical, cosmetic, and biomedical fields; however, its widespread use has been limited by its short half-life. Therefore, a new cross-linked hyaluronic acid was designed and characterized using a natural and safe cross-linking agent, such as arginine methyl ester, which provided improved resistance to enzymatic action, as compared to the corresponding linear polymer. The antibacterial profile of the new derivative was shown to be effective against S. aureus and P. acnes, making it a promising candidate for use in cosmetic formulations and skin applications. Its effect on S. pneumoniae, combined with its excellent tolerability profile on lung cells, also makes this new product suitable for applications involving the respiratory tract.

Publisher

MDPI AG

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3